XML 45 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments (Tables)
9 Months Ended
Sep. 30, 2021
Business Segments [Abstract]  
Segment Reporting Information by Segment
The following tables reflect results of operations from the Company’s business segments for the periods indicated below:

Three Months Ended September 30, 2021

   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Revenues
 
$
5,710
   
$
2,001
   
$
7,711
 
Costs of revenues
   
1,512
     
823
     
2,335
 
Gross profit
   
4,198
     
1,178
     
5,376
 
Gross profit %
   
73.5
%
   
58.9
%
   
69.7
%
                         
Allocated operating expenses:
                       
Engineering and product development
   
333
     
38
     
371
 
Selling and marketing
   
3,094
     
201
     
3,295
 
Unallocated operating expenses
   
-
     
-
     
2,175
 
     
3,427
     
239
     
5,841
 
Income (loss) from operations
   
771
     
939
     
(465
)
Interest expense, net
   
-
     
-
     
(52
)
Income (loss) before income taxes
 
$
771
   
$
939
   
$
(517
)
                                                                                         
Nine Months Ended September 30, 2021

   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Revenues
 
$
15,841
   
$
5,079
   
$
20,920
 
Costs of revenues
   
4,648
     
2,422
     
7,070
 
Gross profit
   
11,193
     
2,657
     
13,850
 
Gross profit %
    70.7 %
    52.3 %
    66.2 %
                         
Allocated operating expenses:
                       
Engineering and product development
   
1,013
     
145
     
1,158
 
Selling and marketing
   
8,805
     
582
     
9,387
 
Unallocated operating expenses
   
-
     
-
     
7,085
 
     
9,818
     
727
     
17,630
 
Income (loss) from operations
   
1,375
     
1,930
     
(3,780
)
Gain on forgiveness of debt
    -       -       2,028  
Interest expense, net
   
-
     
-
     
(93
)
Income (loss) before income taxes
 
$
1,375
   
$
1,930
   
$
(1,845
)


Three Months Ended September 30, 2020

   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Revenues
 
$
3,835
   
$
1,778
   
$
5,613
 
Costs of revenues
   
1,368
     
1,015
     
2,383
 
Gross profit
   
2,467
     
763
     
3,230
 
Gross profit %
   
64.3
%
   
42.9
%
   
57.5
%
                         
Allocated operating expenses:
                       
Engineering and product development
   
329
     
82
     
411
 
Selling and marketing
   
1,883
     
168
     
2,051
 
Unallocated operating expenses
   
-
     
-
     
1,929
 
     
2,212
     
250
     
4,391
 
Income (loss) from operations
   
255
   
513
     
(1,161
)
Interest expense, net
   
-
     
-
     
(21
)
Income (loss) before income taxes
 
$
255
 
$
513
   
$
(1,182
)

Nine Months Ended September 30, 2020

   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Revenues
 
$
12,332
   
$
4,041
   
$
16,373
 
Costs of revenues
   
4,534
     
2,246
     
6,780
 
Gross profit
   
7,798
     
1,795
     
9,593
 
Gross profit %
   
63.2
%
   
44.4
%
   
58.6
%
                         
Allocated operating expenses:
                       
Engineering and product development
   
828
     
122
     
950
 
Selling and marketing
   
6,021
     
425
     
6,446
 
Unallocated operating expenses
   
-
     
-
     
5,921
 

   
6,849
     
547
     
13,317
 
Income (loss) from operations
   
949
     
1,248
     
(3,724
)
Interest expense, net
   
-
     
-
     
(38
)
Income (loss) before income taxes
 
$
949
   
$
1,248
   
$
(3,762
)